Jonathan Faddis Sells 3,000 Shares of Veeva Systems Inc (VEEV) Stock
Veeva Systems Inc (NYSE:VEEV) SVP Jonathan Faddis sold 3,000 shares of the firm’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $101.48, for a total value of $304,440.00. Following the sale, the senior vice president now owns 5,211 shares in the company, valued at approximately $528,812.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Jonathan Faddis also recently made the following trade(s):
- On Monday, June 4th, Jonathan Faddis sold 612 shares of Veeva Systems stock. The stock was sold at an average price of $79.50, for a total value of $48,654.00.
Shares of VEEV opened at $103.40 on Friday. The stock has a market cap of $14.73 billion, a price-to-earnings ratio of 126.82, a P/E/G ratio of 4.85 and a beta of 1.38. Veeva Systems Inc has a 12 month low of $52.17 and a 12 month high of $104.54.
Several institutional investors and hedge funds have recently modified their holdings of the business. Wasatch Advisors Inc. boosted its position in shares of Veeva Systems by 2.8% in the first quarter. Wasatch Advisors Inc. now owns 35,582 shares of the technology company’s stock valued at $2,598,000 after acquiring an additional 967 shares during the period. FDx Advisors Inc. boosted its position in shares of Veeva Systems by 37.8% in the first quarter. FDx Advisors Inc. now owns 9,266 shares of the technology company’s stock valued at $677,000 after acquiring an additional 2,542 shares during the period. Daiwa Securities Group Inc. boosted its position in shares of Veeva Systems by 26.2% in the first quarter. Daiwa Securities Group Inc. now owns 3,975 shares of the technology company’s stock valued at $290,000 after acquiring an additional 825 shares during the period. Mirador Capital Partners LP boosted its position in shares of Veeva Systems by 19.7% in the first quarter. Mirador Capital Partners LP now owns 5,688 shares of the technology company’s stock valued at $399,000 after acquiring an additional 938 shares during the period. Finally, Dynamic Advisor Solutions LLC boosted its position in shares of Veeva Systems by 15.4% in the first quarter. Dynamic Advisor Solutions LLC now owns 8,335 shares of the technology company’s stock valued at $609,000 after acquiring an additional 1,114 shares during the period. Institutional investors own 76.02% of the company’s stock.
Several equities research analysts have recently issued reports on the company. Zacks Investment Research upgraded Veeva Systems from a “hold” rating to a “strong-buy” rating and set a $117.00 price objective on the stock in a report on Wednesday. ValuEngine upgraded Veeva Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday. Deutsche Bank lifted their target price on Veeva Systems from $70.00 to $85.00 and gave the company a “hold” rating in a report on Friday, August 24th. Needham & Company LLC reiterated a “buy” rating and issued a $100.00 target price (up previously from $90.00) on shares of Veeva Systems in a report on Friday, August 24th. Finally, KeyCorp lifted their target price on Veeva Systems from $84.00 to $99.00 and gave the company an “overweight” rating in a report on Friday, August 24th. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and three have assigned a strong buy rating to the company’s stock. Veeva Systems presently has an average rating of “Buy” and a consensus price target of $94.29.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.
Featured Article: Earnings Per Share (EPS) Explained
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.